Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viking Thera (NQ: VKTX ) 64.45 +1.51 (+2.40%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,283,944 Open 63.05 Bid (Size) 63.80 (1) Ask (Size) 65.00 (1) Prev. Close 62.94 Today's Range 62.62 - 66.05 52wk Range 8.280 - 99.41 Shares Outstanding 99,581,693 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments Today 10:07 EDT Terns has a modest market cap of less than $800 million, and its possible upside could be massive. Via The Motley Fool Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 Today 5:49 EDT These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond. Via The Motley Fool Performance YTD +252.57% +252.57% 1 Month -3.27% -3.27% 3 Month +27.27% +27.27% 6 Month -1.12% -1.12% 1 Year +366.52% +366.52% More News Read More What the Options Market Tells Us About Viking Therapeutics September 17, 2024 Via Benzinga 1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc) September 17, 2024 Via The Motley Fool Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now. September 15, 2024 Via The Motley Fool Viking Therapeutics Unusual Options Activity For September 11 September 11, 2024 Via Benzinga If You Invested $1000 In This Stock 5 Years Ago, You Would Have $7,500 Today September 06, 2024 Via Benzinga Stock Market Rally Revives; Apple iPhone 16, Nvidia, Oracle, Adobe In Focus: Weekly Review September 13, 2024 Via Investor's Business Daily These 2 Biotech Stocks Are Set to Soar September 13, 2024 Via The Motley Fool Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735 September 13, 2024 Via The Motley Fool Why Investors Plowed Into Viking Therapeutics Stock Today September 12, 2024 Via The Motley Fool 3 No-Brainer Biotech Stocks to Buy With $200 Right Now September 12, 2024 Via The Motley Fool Why Viking Therapeutics Stock Rocked the Market Today September 11, 2024 Via The Motley Fool Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan September 11, 2024 Via Benzinga Novo Nordisk Jumps After New Weight-Loss Pill Tops Wegovy; Eli Lilly, Viking Shares Rise September 11, 2024 Via Investor's Business Daily Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead? September 07, 2024 Via The Motley Fool Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern September 05, 2024 Via Benzinga Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year September 05, 2024 Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session September 03, 2024 Via Benzinga The Best Biotech Stock to Invest $1,000 in Right Now September 03, 2024 Via The Motley Fool The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race August 29, 2024 Via Investor's Business Daily Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics August 29, 2024 Via Benzinga Why Viking Therapeutics Stock Got Thrashed on Tuesday August 27, 2024 Via The Motley Fool Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug August 27, 2024 Via Investor's Business Daily Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 August 26, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
